Inside

Finding the Cures

Dario Campana
Efforts to harness natural killer (NK) cells for cancer treatment advanced recently thanks to a St. Jude strategy that dramatically boosts production of the powerful, but rare immune component.
 

Basic Science

The diverse research at St. Jude ranges from discovery-focused and hypothesis-testing laboratory studies to clinical trials of specific agents, regimens, or therapeutic interventions. We continually seek to translate knowledge acquired through basic research into novel approaches for clinical diagnosis and treatment. At the same time, our clinical and laboratory-based investigators use the challenges encountered in the clinic to focus the efforts of our research.

The Research Behind the Cures

Drs. Downing and Mullighan

Mutant genes identified in high-risk childhood leukemias

A research team has pinpointed a new class of gene mutations, which identify cases of childhood acute lymphoblastic leukemia (ALL) that have a high risk of relapse and death.

Read More

Scientific Report 2008

Scientific Report

Key research activities and publications by the investigators at St. Jude during 2007 are summarized in the Scientific Report 2008.

In the News

Charles Mullighan
Charles Mullighan, MD, PhD, an assistant member in the Pathology Department at St. Jude Children’s Research Hospital, has been named a 2009 Pew Scholar in the Biomedical Sciences. He is the fourth St. Jude scientist honored.

Interactive / Multimedia